144 related articles for article (PubMed ID: 25518879)
21. Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancer.
Chang JY; Liu YH; Zhu Z; Welsh JW; Gomez DR; Komaki R; Roth JA; Swisher SG
Cancer; 2013 Sep; 119(18):3402-10. PubMed ID: 23798353
[TBL] [Abstract][Full Text] [Related]
22. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer.
Zimmermann FB; Geinitz H; Schill S; Grosu A; Schratzenstaller U; Molls M; Jeremic B
Lung Cancer; 2005 Apr; 48(1):107-14. PubMed ID: 15777977
[TBL] [Abstract][Full Text] [Related]
24. Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors.
Park Y; Kim HJ; Chang AR
Radiat Oncol; 2017 Apr; 12(1):66. PubMed ID: 28381302
[TBL] [Abstract][Full Text] [Related]
25. Repeat stereotactic body radiation therapy for patients with pulmonary malignancies who had previously received SBRT to the same or an adjacent tumor site.
Valakh V; Miyamoto C; Micaily B; Chan P; Neicu T; Li S
J Cancer Res Ther; 2013; 9(4):680-5. PubMed ID: 24518717
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic Body Radiotherapy for Synchronous Primary Lung Cancer: Clinical Outcome of 18 Cases.
Shintani T; Masago K; Takayama K; Ueki K; Kimino G; Ueki N; Kosaka Y; Imagumbai T; Katakami N; Kokubo M
Clin Lung Cancer; 2015 Sep; 16(5):e91-6. PubMed ID: 25659504
[TBL] [Abstract][Full Text] [Related]
28. Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity.
Murray L; Karakaya E; Hinsley S; Naisbitt M; Lilley J; Snee M; Clarke K; Musunuru HB; Ramasamy S; Turner R; Franks K
Br J Radiol; 2016; 89(1058):20150628. PubMed ID: 26760508
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm.
Takeda A; Sanuki N; Kunieda E; Ohashi T; Oku Y; Takeda T; Shigematsu N; Kubo A
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):442-8. PubMed ID: 18990507
[TBL] [Abstract][Full Text] [Related]
30. Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife.
Brown WT; Wu X; Amendola B; Perman M; Han H; Fayad F; Garcia S; Lewin A; Abitbol A; de la Zerda A; Schwade JG
Cancer J; 2007; 13(2):87-94. PubMed ID: 17476136
[TBL] [Abstract][Full Text] [Related]
31. Stereotactic body radiation therapy for unbiopsied early-stage lung cancer: a multi-institutional analysis.
Harkenrider MM; Bertke MH; Dunlap NE
Am J Clin Oncol; 2014 Aug; 37(4):337-42. PubMed ID: 23660597
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic ablative radiotherapy for medically inoperable early stage lung cancer: early outcomes.
Chan OS; Yeung RM; Hung AW; Lee MC; Chang AT; Chan CC; Lee AW
Hong Kong Med J; 2012 Oct; 18(5):412-8. PubMed ID: 23018069
[TBL] [Abstract][Full Text] [Related]
33. Stereotactic body radiotherapy in patients with previous pneumonectomy: safety and efficacy.
Thompson R; Giuliani M; Yap ML; Atallah S; Le LW; Sun A; Brade A; Cho BC; Bezjak A; Hope A
J Thorac Oncol; 2014 Jun; 9(6):843-7. PubMed ID: 24828663
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer.
Hiraoka M; Matsuo Y; Nagata Y
Cancer Radiother; 2007; 11(1-2):32-5. PubMed ID: 17158081
[TBL] [Abstract][Full Text] [Related]
35. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.
Senthi S; Lagerwaard FJ; Haasbeek CJ; Slotman BJ; Senan S
Lancet Oncol; 2012 Aug; 13(8):802-9. PubMed ID: 22727222
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
[TBL] [Abstract][Full Text] [Related]
37. [Stereotactic radiotherapy for stage I and II lung cancer: a study of 33 patients].
Champeaux-Orange E; Wachter T; Bouscayrol H; Barillot I
Cancer Radiother; 2011 Jun; 15(3):192-6. PubMed ID: 21330178
[TBL] [Abstract][Full Text] [Related]
38. 30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancer.
Videtic GM; Stephans KL; Woody NM; Reddy CA; Zhuang T; Magnelli A; Djemil T
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):203-8. PubMed ID: 25015198
[TBL] [Abstract][Full Text] [Related]
39. Image-guided stereotactic ablative radiotherapy for the liver: a safe and effective treatment.
Van De Voorde L; Vanneste B; Houben R; Damen P; van den Bogaard J; Lammering G; Dejong K; de Vos-Geelen J; Buijsen J; Öllers M; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Feb; 41(2):249-56. PubMed ID: 25468743
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
